BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tawfik HO, Petreni A, Supuran CT, El-Hamamsy MH. Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach. Eur J Med Chem 2022;232:114190. [PMID: 35182815 DOI: 10.1016/j.ejmech.2022.114190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liguori F, Carradori S, Ronca R, Rezzola S, Filiberti S, Carta F, Turati M, Supuran CT. Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells. J Enzyme Inhib Med Chem 2022;37:1857-69. [PMID: 35768159 DOI: 10.1080/14756366.2022.2091557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Arrighi G, Puerta A, Petrini A, Hicke FJ, Nocentini A, Fernandes MX, Padrón JM, Supuran CT, Fernández-bolaños JG, López Ó. Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. IJMS 2022;23:7685. [DOI: 10.3390/ijms23147685] [Reference Citation Analysis]
3 Abdoli M, Giovannuzzi S, Supuran CT, Žalubovskis R. 4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:1568-76. [DOI: 10.1080/14756366.2022.2080816] [Reference Citation Analysis]
4 Denner TC, Hoenke S, Kraft O, Deigner H, Al-harrasi A, Csuk R. Hydroxyethylamide substituted triterpenoic acids hold good cytotoxicity for human tumor cells. Results in Chemistry 2022. [DOI: 10.1016/j.rechem.2022.100371] [Reference Citation Analysis]